Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001194290 | SCV001363696 | benign | not specified | 2019-08-09 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001514422 | SCV001722263 | benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001813579 | SCV002060545 | benign | Noonan syndrome and Noonan-related syndrome | 2021-02-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002451405 | SCV002613808 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2020-08-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004545115 | SCV004759331 | likely benign | LZTR1-related disorder | 2022-01-21 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |